Clinical Trial Update: Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating decitabine in patients with unresectable lung cancer, esophageal cancer, or malignant mesothelioma of the pleura; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Lung Cancer
• Malignant Mesothelioma

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Esophageal Cancer, Lung Cancer | Phase 1 | Status: COMPLETED